Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's diseaseFrank M. Ruemmele, Dan Turner, Stephan Buderus et al.|Journal of Crohn s and Colitis|2014Cited by 1.1k
Efficacy and Safety of Pantoprazole Delayed‐release Granules for Oral Suspension in a Placebo‐controlled Treatment‐withdrawal Study in Infants 1–11 Months Old With Symptomatic GERDHarland S. Winter, Gail M. Comer, Philip Kum‐Nji et al.|Journal of Pediatric Gastroenterology and Nutrition|2010Cited by 74
High‐ and Low‐Dose Oral Delayed‐Release Mesalamine in Children With Mild‐to‐Moderately Active Ulcerative ColitisHarland S. Winter, Preston Dunnmon, Piotr Krzeski et al.|Journal of Pediatric Gastroenterology and Nutrition|2014Cited by 25
DOP008 Safety of adalimumab in children and adolescents with moderate-to-severe Crohn’s disease: interim results of the CAPE registryDan Turner, Frank M. Ruemmele, Sibylle Koletzko et al.|Journal of Crohn s and Colitis|2018Cited by 0
Efficacy and Tolerability of Pantoprazole Delayed-Release Granules for Oral Suspension in a Placebo-Controlled Treatment-Withdrawal Study in Infants 1 Through 11 Months of Age with Symptomatic GERDGail M. Comer, Harland S. Winter, Philip Kum‐Nji et al.|The American Journal of Gastroenterology|2008Cited by 0